Literature DB >> 20930001

Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study.

Chris Adamopoulos1, Philippe Meyer, Ravi V Desai, Kyparissi Karatzidou, Fernando Ovalle, Michel White, Inmaculada Aban, Thomas E Love, Prakash Deedwania, Stefan D Anker, Ali Ahmed.   

Abstract

AIMS: Obesity is paradoxically associated with survival benefit in patients with chronic heart failure (HF). However, obesity complicates the management of diabetes mellitus (DM), which is common in HF. Yet, little is known about the impact of obesity in HF patients with DM. Therefore, we examined the association between obesity and outcomes in propensity-matched cohorts of HF patient with and without DM. METHODS AND
RESULTS: Of the 7788 participants with chronic mild to moderate HF in the Digitalis Investigation Group trial, 7379 were non-cachectic [body mass index (BMI) ≥ 20 kg/m²] at baseline. Of these, 2153 (29%) had DM, of whom 798 (37%) were obese (BMI ≥ 30 kg/m²). Of the 5226 patients without DM, 1162 (22%) were obese. Propensity scores for obesity were used to separately assemble 636 pairs of obese and non-obese patients with DM and 770 pairs of obese and non-obese patients without DM, who were balanced on 32 baseline characteristics. Among matched patients with DM, all-cause mortality occurred in 38 and 39% of obese and non-obese patients, respectively [hazard ratio (HR) when obesity was compared with no obesity 0.99; 95% confidence interval (CI) 0.80-1.22; P = 0.915]. Among matched patients without DM, all-cause mortality occurred in 23 and 27% obese and non-obese patients, respectively (HR associated with obesity 0.77; 95% CI 0.61-0.97; P = 0.025).
CONCLUSION: In patients with chronic mild to moderate HF and DM, obesity confers no paradoxical survival benefit. Whether intentional weight loss may improve outcomes in these patients needs to be investigated in future prospective studies.

Entities:  

Mesh:

Year:  2010        PMID: 20930001      PMCID: PMC3025667          DOI: 10.1093/eurjhf/hfq159

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  31 in total

Review 1.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Authors:  Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg
Journal:  Eur J Heart Fail       Date:  2008-09-16       Impact factor: 15.534

2.  Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods.

Authors:  Ali Ahmed; Ahsan Husain; Thomas E Love; Giovanni Gambassi; Louis J Dell'Italia; Gary S Francis; Mihai Gheorghiade; Richard M Allman; Sreelatha Meleth; Robert C Bourge
Journal:  Eur Heart J       Date:  2006-05-18       Impact factor: 29.983

3.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

Review 4.  Body mass index and mortality in heart failure: a meta-analysis.

Authors:  Antigone Oreopoulos; Raj Padwal; Kamyar Kalantar-Zadeh; Gregg C Fonarow; Colleen M Norris; Finlay A McAlister
Journal:  Am Heart J       Date:  2008-07       Impact factor: 4.749

5.  A propensity-matched study of the effect of diabetes on the natural history of heart failure: variations by sex and age.

Authors:  Ali Ahmed; Inmaculada B Aban; Viola Vaccarino; Donald M Lloyd-Jones; David C Goff; Jiannan Zhao; Thomas E Love; Christine Ritchie; Fernando Ovalle; Giovanni Gambassi; Louis J Dell'Italia
Journal:  Heart       Date:  2007-05-08       Impact factor: 5.994

6.  Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.

Authors:  John J V McMurray; Peter E Carson; Michel Komajda; Robert McKelvie; Michael R Zile; Agata Ptaszynska; Christoph Staiger; J Mark Donovan; Barry M Massie
Journal:  Eur J Heart Fail       Date:  2008-02       Impact factor: 15.534

7.  Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries.

Authors:  Jawdat Abdulla; Lars Køber; Steen Z Abildstrøm; Erik Christensen; W Philip T James; Christian Torp-Pedersen
Journal:  Eur Heart J       Date:  2008-02-12       Impact factor: 29.983

8.  Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

Authors:  Michael R MacDonald; Mark C Petrie; Fumi Varyani; Jan Ostergren; Eric L Michelson; James B Young; Scott D Solomon; Christopher B Granger; Karl Swedberg; Salim Yusuf; Marc A Pfeffer; John J V McMurray
Journal:  Eur Heart J       Date:  2008-04-14       Impact factor: 29.983

9.  Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.

Authors:  Xavier Pi-Sunyer; George Blackburn; Frederick L Brancati; George A Bray; Renee Bright; Jeanne M Clark; Jeffrey M Curtis; Mark A Espeland; John P Foreyt; Kathryn Graves; Steven M Haffner; Barbara Harrison; James O Hill; Edward S Horton; John Jakicic; Robert W Jeffery; Karen C Johnson; Steven Kahn; David E Kelley; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Brenda Montgomery; David M Nathan; Jennifer Patricio; Anne Peters; J Bruce Redmon; Rebecca S Reeves; Donna H Ryan; Monika Safford; Brent Van Dorsten; Thomas A Wadden; Lynne Wagenknecht; Jacqueline Wesche-Thobaben; Rena R Wing; Susan Z Yanovski
Journal:  Diabetes Care       Date:  2007-03-15       Impact factor: 19.112

10.  Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.

Authors:  Satish Kenchaiah; Stuart J Pocock; Duolao Wang; Peter V Finn; Leonardo A M Zornoff; Hicham Skali; Marc A Pfeffer; Salim Yusuf; Karl Swedberg; Eric L Michelson; Christopher B Granger; John J V McMurray; Scott D Solomon
Journal:  Circulation       Date:  2007-07-16       Impact factor: 29.690

View more
  33 in total

1.  Impairment of activities of daily living and incident heart failure in community-dwelling older adults.

Authors:  C Barrett Bowling; Gregg C Fonarow; Kanan Patel; Yan Zhang; Margaret A Feller; Xuemei Sui; Steven N Blair; Kannayiram Alagiakrishnan; Inmaculada B Aban; Thomas E Love; Richard M Allman; Ali Ahmed
Journal:  Eur J Heart Fail       Date:  2012-04-04       Impact factor: 15.534

2.  Relationship between stage of kidney disease and incident heart failure in older adults.

Authors:  C Barrett Bowling; Margaret A Feller; Marjan Mujib; Pushkar P Pawar; Yan Zhang; O James Ekundayo; Inmaculada B Aban; Thomas E Love; Paul W Sanders; Stefan D Anker; Gregg C Fonarow; Ali Ahmed
Journal:  Am J Nephrol       Date:  2011-07-04       Impact factor: 3.754

3.  Adiposity facilitates increased strength capacity in heart failure patients with reduced ejection fraction.

Authors:  Alexandra Zavin; Karla Daniels; Ross Arena; Kelly Allsup; Antonio Lazzari; Jacob Joseph; P Christian Schulze; Stewart H Lecker; Daniel E Forman
Journal:  Int J Cardiol       Date:  2012-06-27       Impact factor: 4.164

4.  Index event bias as an explanation for the paradoxes of recurrence risk research.

Authors:  Issa J Dahabreh; David M Kent
Journal:  JAMA       Date:  2011-02-23       Impact factor: 56.272

5.  Impact of Body Mass Index on Activities of Daily Living in Inpatients with Acute Heart Failure.

Authors:  H Wakabayashi; K Maeda; S Nishioka; H Shamoto; R Momosaki
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

6.  Intrinsic association of widowhood with mortality in community-dwelling older women and men: findings from a prospective propensity-matched population study.

Authors:  Beverly R Williams; Yan Zhang; Patricia Sawyer; Marjan Mujib; Linda G Jones; Margaret A Feller; O James Ekundayo; Inmaculada B Aban; Thomas E Love; Amy Lott; Ali Ahmed
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-09-07       Impact factor: 6.053

7.  Smoking and mortality in stroke survivors: can we eliminate the paradox?

Authors:  Deborah A Levine; James M Walter; Sudeep J Karve; Lesli E Skolarus; Steven R Levine; Kristine A Mulhorn
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-01-15       Impact factor: 2.136

Review 8.  Obesity paradox in heart failure: statistical artifact, or impetus to rethink clinical practice?

Authors:  Richard Charnigo; Maya Guglin
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

9.  The impact of inflammation on the obesity paradox in coronary heart disease.

Authors:  A De Schutter; S Kachur; C J Lavie; R S Boddepalli; D A Patel; R V Milani
Journal:  Int J Obes (Lond)       Date:  2016-07-25       Impact factor: 5.095

10.  Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease.

Authors:  Ali Ahmed; Michael W Rich; Michael Zile; Paul W Sanders; Kanan Patel; Yan Zhang; Inmaculada B Aban; Thomas E Love; Gregg C Fonarow; Wilbert S Aronow; Richard M Allman
Journal:  Am J Med       Date:  2013-02       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.